Spectrum of malignant somatostatin-producing neuroendocrine tumors

Endocrine Practice

Volumn 12, Issue 4, 2006, Pages 394-400

  Moayedoddin, Baback ^a   Booya, Fargol ^b   Wermers, Robert A ^b   Lloyd, Ricardo V ^b   Rubin, Joseph ^b   Thompson, Geoffrey B ^b   Fatourechi, Vahab ^b  

^a University of Paris   (France)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2;

ABDOMEN; ADULT; AGED; ARTICLE; BLOOD LEVEL; CHOLELITHIASIS; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DUODENUM CANCER; FEMALE; HEPATIC ARTERY LIGATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; NEUROENDOCRINE TUMOR; NEUROFIBROMATOSIS; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREATICODUODENECTOMY; PARTIAL HEPATECTOMY; PSAMMOMA BODY; RETROSPECTIVE STUDY; SOMATOSTATINOMA; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TUMOR VOLUME; DUODENUM TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; SURVIVAL;

ADULT; AGED; DUODENAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; RETROSPECTIVE STUDIES; SOMATOSTATIN; SOMATOSTATINOMA; SURVIVAL ANALYSIS;

EID: 33750112499     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.12.4.394     Document Type: Article

References (26)

1. Soga J, Yakuwa Y. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res. 1999;18:13-22.
2. Ganda OP, Weir GC, Soeldner JS, et al. "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas. N Engl J Med. 1977;296:963-967.
3. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
4. Green BT, Rockey DC. Duodenal somatostatinoma presenting with complete somatostatinoma syndrome. J Clin Gastroenterol. 2001;33:415-417.
5. Buetow PC, Miller DL, Parrino TV, Buck JL. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization [erratum in Radiographics. 1997;17:1010]. Radiographics. 1997;17: 453-472; quiz 472A-472B.
6. Lamers CB. Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract. Acta Endocrinol Suppl (Copenh). 1987;286:19-25.
7. Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol. 2001;12(Suppl 2):S95-S99.
8. Bronisz A, Junik R. Pancreatic islets endocrinopathies with disorders of carbohydrate metabolism - Part 2: somatostatinoma, VIP-oma, PP-oma [article in Polish]. Pol Arch Med Wewn. 2004;112:853-858.
9. Schusdziarra V, Grube D, Seifert H, et al. Somatostatinoma syndrome: clinical, morphological and metabolic features and therapeutic aspects. Klin Wochenschr. 1983;61:681-689.
10. Varas Lorenzo MJ. Somatostatinoma syndrome [article in Spanish]. Med Clin (Barc). 1982;78:246-249.
11. Larsson LI, Hirsch MA, Holst JJ, et al. Pancreatic somatostatinoma: clinical features and physiological implications. Lancet. 1977;1:666-669.
12. Marakis G, Ballas K, Rafailidis S, Alatsakis M, Patsiaoura K, Sakadamis A. Somatostatin-producing pancreatic endocrine carcinoma presented as relapsing cholangitis - a case report. Pancreatology. 2005;5:295-299.
13. Maselli MA, Peipoli AL, Pezzolla F, Caruso ML, Lorusso D. Effect of somatostatin on human gallbladder motility: an in vitro study. Neurogastroenterol Motil. 1999;11:47-53.
14. Yamasaki T, Chijiiwa K, Chijiiwa Y. Somatostatin inhibits cholecystokinin-induced contraction of isolated gallbladder smooth muscle cells. J Surg Res. 1995;59:743-746.
15. Fraquelli M, Pagliarulo M, Colucci A, Paggi S, Conte D. Gallbladder motility in obesity, diabetes mellitus and coeliac disease. Dig Liver Dis. 2003;35(Suppl 3):S12-S16.
16. Marteau P, Chretien Y, Calmus Y, Parc R, Poupon R. Pharmacological effect of somatostatin on bile secretion in man. Digestion. 1989;42:16-21.
17. Sessa F, Arcidiaco M, Valenti L, Solcia M, Di Maggio E, Solcia E. Metastatic psammomatous somatostatinoma of the pancreas causing severe ketoacidotic diabetes cured by surgery. Endocr Pathol. 1997;8:327-333.
18. Kim DM, Ahn CW, Kim KR, et al. Duodenal somatostatinoma presenting with diabetic ketoacidosis presumably caused by somatostatin-28 hypersecretion. J Clin Endocrinol Metab. 2005;90:6310-6315.
19. Blaser A, Vajda P, Rosset P. Duodenal somatostatinomas associated with von Recklinghausen disease [article in French]. Schweiz Med Wochenschr. 1998;128:1984-1987.
20. Usui M, Matsuda S, Suzuki H, Hirata K, Ogura Y, Shiraishi T. Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromal tumors in a patient with von Recklinghausen's disease. J Gastroenterol. 2002;37: 947-953.
21. Patel VG, Henderson VJ, Fairweather DA, et al. Malignant duodenal somatostatinoma presenting in association with von Recklinghausen disease. Am Surg. 2003;69: 1077-1082.
22. Cappelli C, Agosti B, Braga M, et al. Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma: a case report and review of the literature. Minerva Endocrinol. 2004;29:19-24.
23. Maki M, Kaneko Y, Ohta Y, Nakamura T, Machinami R, Kurokawa K. Somatostatinoma of the pancreas associated with von Hippel-Lindau disease. Intern Med. 1995;34:661-665.
24. Levy-Bohbot N, Merle C, Goudet P, et al (Groupe des Tumeurs Endocrines). Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol Clin Biol. 2004;28:1075-1081.
25. House MG, Yeo CJ, Schulick RD. Periampullary pancreatic somatostatinoma. Ann Surg Oncol. 2002;9:869-874.
26. Azimuddin K, Chamberlain RS. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am. 2001;81:511-525.